GALNS gene expression profiling in Morquio A patients' fibroblasts

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• Quantification studies of mutated mRNAs in Morquio A patients are lacking.
• Assessing the stability of premature termination codon (PTC) bearing transcripts is vital for evaluating new therapies like stop codon read-through therapy.

Purpose of the Study:

• To develop and validate a rapid real-time RT-PCR assay for detecting and quantifying absolute mRNA copy numbers of the GALNS gene.
• To study GALNS gene and mRNA in fibroblasts from two severe Morquio A patients.

Main Methods:

• Development of a novel, rapid real-time RT-PCR assay.
• Absolute quantification of GALNS mRNA copy number.
• Analysis of mRNA from patient-derived fibroblasts.

Main Results:

• Identified two new mutations (c.385A>T and c.899-1G>C) in one patient and a known splicing defect (c.120+1G>A) in another.
• Detected low mRNA levels in one patient, indicating instability.
• Observed three aberrant mRNAs with premature stop codons in the other patient, suggesting escape from nonsense-mediated decay (NMD).

Conclusions:

• A real-time RT-PCR assay was successfully developed to quantify GALNS mRNAs with mutations leading to PTCs.
• These PTC-bearing transcripts escape NMD, making them potentially suitable targets for novel therapeutic strategies.
• The study provides a foundation for assessing therapeutic interventions for Morquio A patients based on mRNA analysis.